Professor Dame Pamela J Shaw
DBE, MBBS, MD, FRCP, FMedSci, FAAN, FANA, FAAAS
Neuroscience, School of Medicine and Population Health
Director of the 91直播 Institute for Translational Neuroscience (SITraN)
Professor of Neurology
Director, NIHR Biomedical Research Centre Translational Neuroscience for Chronic Neurological Disorders
Director, 91直播 Care and Research Centre for Motor Neuron Disorders
Director, Cross-Faculty Flagship Neuroscience Institute
Honorary Consultant Neurologist, 91直播 Teaching Hospitals NHS Foundation Trust
+44 114 222 2295
Full contact details
Neuroscience, School of Medicine and Population Health
91直播 Institute for Translational Neuroscience (SITraN)
385a Glossop Road
91直播
S10 2HQ
- Profile
-
Pamela Shaw is an academic neurologist and a world-leading researcher in motor neuron disease (MND). She has held extensive leadership roles at local/national/international levels including: Director-91直播 Institute for Translational Neuroscience (SITraN) (2010-present); Director University of 91直播 Cross-Faculty Neuroscience Institute (2019-present); Pro-Vice Chancellor Faculty of Health (2016-2019). NIHR leadership roles include DeNDRoN Associate Director (2006-15);Yorkshire&Humber CRN Division 4 Lead (2014-16);Director-91直播 NIHR BRC (2017-present). Nationally she led the Association of British Neurologists (ABN) Clinical Research Academic Committee and served as panel member for MRC, Wellcome, Academy Medical Sciences, UKRI, Lister Institute, NIHR Senior Investigator awards. Internationally she is a founding/executive member of ENCALS and chaired the International Scientific Programme Committee for ALS/MND (2004-10).
She has systematically built scientific and clinical facilities and diverse, multidisciplinary teams to deliver effective translational research for neurodegeneration. She uses genetics and biological studies in pre-clinical model systems linked to human biosamples, to define novel pathways of disease, and to identify promising small molecule and gene-therapy targets, together with novel biomarkers.
Significant contributions from MND clinical research include: identification and introduction into clinical practice of riluzole; evaluation of further potential neuroprotective therapies in >22 clinical trials; demonstration that support with non-invasive ventilation (NIV) has a major positive impact on QOL and survival which changed management internationally. She has contributed significantly to the genetic subclassification of MND including identification of changes in CHMP2B;TARDB;FUS;C9ORF72;TUBA4A;NEK1;Annexin A11;GLT8D1 genes, together with the associated clinical phenotype and molecular pathology. She has also demonstrated the value of offering routine genetic screening for MND patients.
Her team has generated a translational pipeline of potential neuroprotective therapies. Using viral vectors (AAV9) to deliver neuroprotective cargoes to the CNS, she has demonstrated dramatic therapeutic effects in pre-clinical models of SOD1-MND and SMA. This work has underpinned successful experimental medicine trials. Transcriptomic work has identified several pathways which can be modified therapeutically including the NRF2-anti-oxidant response and SRSF1, which are currently being developed towards MND clinical trials.
She has authored >560 publications (H-index 116, Citations 48,225) and secured >拢140m in research funding. She has supervised and mentored the career development of >190 young scientists and clinicians, including 55 PhD students. She has delivered >600 presentations at national/international venues including many plenary/keynote invited lectures.
Multiple awards recognising her translational research contributions include: NIHR Senior Investigator Award-2013-2021; DBE for Services to Neuroscience-2014; American Academy of Neurology Sheila Essey Award-2001;International ALS/MND Alliance Forbes Norris Award-2007;Royal College of Physicians Jean Hunter Award-2006/Croonian Lecture-2016; FMedSci-2007; Fellowship American Association for the Advancement of Science-2015;ABN Medallist-2019; Queen鈥檚 Anniversary Award to SITraN-2019; Singhal Award Lecture World Congress of Neurology 2021; Platinum Clinical Excellence Award-2013-present; British Neuroscience Research Excellence award 2022.
She has supported academic capacity development locally, building a department of >300 staff and graduate students since 2000 and nationally through DeNDroN and the ABN. She has mentored future research leaders through the NIHR Academy and the Academy of Medical Sciences. As Pro-VC she led the Medical School Athena Swan Silver award and promoted the Faculty Equality-Diversity-Inclusion agenda appointing a Faculty EDI Director and introducing mandatory EDI staff training.
Professor Shaw graduated in Medicine with 1st Class Honours from the University of Newcastle in 1979. She undertook her MRCP and Specialist Training in Neurology in Newcastle.
In 1988 she was awarded an MD with commendation for her work on the neurological complications of coronary bypass surgery. After an intermediate fellowship award from the Wellcome Trust, she was awarded a Wellcome Senior Fellowship in Clinical Science which she held from 1991 -2001.
In 1997 she was appointed Professor of Neurological Medicine at the University of Newcastle and in 2000 was appointed as Professor of Neurology at the University of 91直播.
As an undergraduate in Newcastle she was awarded the Stephen Scott; Gibb; Mary Gordon; Mona McNaughton and Phillipson Prizes/Scholarships and achieved distinction in all undergraduate examinations.
- Research interests
-
Professor Shaw is a Clinician Scientist in Neurology, an emeritus NIHR Senior Investigator and formerly a Wellcome Senior Clinical Fellow. Supported by long-term programme funding from the Wellcome Trust, she has since 1991 led a major multidisciplinary programme of research investigating genetic, molecular and neurochemical factors underlying neurodegenerative disorders of the human motor system.
Her team use robust cellular and in vivo models of neurodegeneration and correlate key findings with disease related changes in the human nervous system. Significant research achievements include:
- Identification of cell specific features of motor neurons which underlie susceptibility to neurodegeneration.
- Understanding the cellular pathways of motor neuron injury in the presence of mutant SOD1 using a combination of cell biology, proteomics and gene expression profiling.
- Subclassification of motor neuron disease (MND) based on genetics and molecular pathology.
- Development of new small molecule and gene therapy candidate treatments for patients using staged screening programmes in cellular and other experimental model systems linked to human biosamples.
- Promoting the introduction of neuroprotective treatments for MND into trials and clinical practice e.g. riluzole, tofersen, aldesleukin.
- Establishing the role of non-invasive ventilation (NIV) in improving the quality of life and prolonging survival of MND patients.
Professor Shaw鈥檚 research is currently funded by the Medical Research Council, NIHR, LifeArc, the Motor Neurone Disease Association, the My Name鈥5 Doddie Foundation, Fight MND, the US Department of Defence, the European Union and biotechnology & pharmaceutical industry partners.
Current projects
Professor Shaw鈥檚 research is focused on 3 main goals:
- To understand the function of motor neurons in health and disease and to translate basic science findings into health benefits for patients with degenerative motor system disorders.
- To provide excellent clinical care for patients with motor system disorders, at all disease stages incorporating: multidisciplinary team working, evidence based standards of care for symptomatic management, and evaluation of new neuroprotective therapies.
- To foster excellent training for clinical and scientific junior staff with the aim of ensuring high standards of future care and linking new developments in medical science firmly to the needs of patients with neurological disorders.
Since 1983 she has supervised the research training of > 190 individuals from medicine and science including 55 PhD/MD students.
Professor Shaw is the Director of the NIHR 91直播 Biomedical Research Centre translating new potential treatments from SITraN research into early phase and experimental medicine clinical trials
- Publications
-
Journal articles
- . Journal of Neurology, 272(1).
- . Life Science Alliance, 8(2), e202402757-e202402757.
- .
- . The Cognitive Behaviour Therapist, 17.
- . Cell Genomics, 100679-100679.
- . Annals of Neurology.
- . The Lancet Neurology.
- . Molecular Therapy.
- . Neurology, 103(2).
- . Life Science Alliance, 7(9), e202402853-e202402853.
- . Annals of Clinical and Translational Neurology.
- . Bioinformatics, 40(6).
- . Annals of the New York Academy of Sciences.
- . The Lancet.
- . Fluids and Barriers of the CNS, 21(1).
- . Muscle & Nerve, 69(6), 733-734.
- . The Analyst.
- . Heliyon, 10(3), e24975-e24975.
- .
- . Alzheimer's & Dementia, 19(S13).
- . Trials, 24(1).
- . Translational Neurodegeneration, 12(1).
- . Pilot and Feasibility Studies, 9.
- . Neurobiology of Disease, 180, 106082-106082.
- . Frontiers in Cellular Neuroscience, 17.
- . Science Translational Medicine, 15(685).
- . Frontiers in Pain Research, 3.
- . Neurology - Neuroimmunology Neuroinflammation, 10(1), e200042-e200042.
- . Life Science Alliance, 6(1), e202201449-e202201449.
- . Frontiers in Cellular Neuroscience, 16.
- . Frontiers in Cellular Neuroscience, 16.
- . International Journal of Molecular Sciences, 23(23).
- . Nature Communications, 13(1).
- . Brain, 145(12), 4440-4447.
- . New England Journal of Medicine, 387(12), 1099-1110.
- . The Lancet.
- . Journal of Neurology, Neurosurgery & Psychiatry, 93(9), e2.136-e2.136.
- . Journal of Neurology, Neurosurgery & Psychiatry, 93(9), e2.130-e2.130.
- . Journal of Neurology, Neurosurgery & Psychiatry, 93(9), e2.208-e2.208.
- . iScience, 104877-104877.
- . Brain Pathology.
- . Muscle and Nerve.
- . Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A13.2-A13.
- . Journal of Neurology, Neurosurgery & Psychiatry, 93(6), A10.1-A10.
- . Clinical Neurophysiology, 139, 69-75.
- . Analyst.
- . Human Molecular Genetics.
- . Cells, 11(7).
- . Nature Neuroscience, 25(4), 433-445.
- . Brain Communications, 4(2).
- . Science Translational Medicine, 14(633).
- . Brain Communications, 4(1).
- . Nature Genetics, 54(3), 361-361.
- . npj Genomic Medicine, 7(1).
- . Neuron.
- . Circulation Research, 130(2), 166-180.
- . Brain, 145(3), 832-842.
- . Journal of Raman Spectroscopy, 53(2), 172-181.
- . Muscle & Nerve, 65(2), 203-210.
- . Journal of Magnetic Resonance Imaging, 55(2), 435-442.
- . Frontiers in Neuroscience, 15.
- . Essays in Biochemistry, 65(7), 999-1011.
- . Nature Genetics, 53(12), 1636-1648.
- . Physiological Measurement, 42(10).
- . JAMA Neurology, 78(10), 1236-1248.
- . Journal of the Neurological Sciences, 429, 117636-117636.
- . Journal of the Neurological Sciences, 429, 119412-119412.
- . Neurology, 97(11), 528-536.
- . Neurobiology of Aging, 105, 64-77.
- . Free Radical Biology and Medicine, 173, 125-141.
- . Scientific Reports, 11(1).
- . Brain Communications, 3(3).
- . Molecular Neurodegeneration, 16(1).
- . British Journal of Surgery, 108(11), 1274-1292.
- . Molecular Therapy 鈥 Methods & Clinical Development, 21, 413-433.
- . Frontiers in Molecular Neuroscience, 14.
- . EBioMedicine, 68.
- . ACS Chemical Neuroscience, 12(10), 1768-1776.
- . Genome Biology, 22.
- . Journal of Neurology, Neurosurgery & Psychiatry, 92(5), 510-518.
- . Neuropathology and Applied Neurobiology, 47(1), 61-72.
- . Cell Reports, 34(5), 108730-108730.
- . BMC Medicine, 19(1).
- . Aging Cell, 20(1).
- . Annals of Neurology, 89(4), 686-697.
- . Brain, 143(12), 3603-3618.
- . Biomedicines, 9(1).
- . Acta Neuropathologica Communications, 9(1).
- . Neuron, 109(3), 448-460.e4.
- . NAR Genomics and Bioinformatics, 2(4).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(7-8), 579-582.
- . Physiological Measurement, 41(12).
- . Cell Reports, 33(9), ---.
- . Expert Opinion on Orphan Drugs, 8(10), 379-392.
- . Current Opinion in Neurology, 33(5), 662-668.
- . BMC Genetics, 21(1).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22(1-2), 38-45.
- . Journal of Neuropathology & Experimental Neurology, 79(9), 950-958.
- . EBioMedicine, 59.
- . Circulation, 142(4), 324-338.
- . New England Journal of Medicine, 383(2), 109-119.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(7-8), 627-630.
- . Amyotrophic lateral sclerosis & frontotemporal degeneration, 21(5-6), 435-444.
- . The Journal of Pathology, 251(3), 262-271.
- . Brain Communications, 2(2).
- . Neuropathology & Applied Neurobiology, 46(3), 279-291.
- . Brain, 143(5), 1332-1340.
- . Journal of Personalized Medicine, 10(2).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 21(3-4), 222-227.
- . Neurology, 94(15_supplement).
- . Neurology, 94(15_supplement).
- . Clinical Neurophysiology, 131(4), 799-808.
- . Journal of Neurology, 267(1), 244-256.
- . Journal of Neurology, 267(1), 257-258.
- . Nature Neuroscience, 23(2), 295-295.
- . Science Translational Medicine, 11(523).
- . Nature Neuroscience, 22(12), 1966-1974.
- . Brain, 142(12), 3771-3790.
- . Acta Neuropathologica Communications, 7(1).
- . Clinical Nutrition.
- . Journal of Neurology, Neurosurgery & Psychiatry, 90(12), 1331-1337.
- . British Journal of Health Psychology, 24(4), 953-969.
- . BMJ Open, 9.
- . BMJ Open, 9(10).
- . Neuropathology and Applied Neurobiology, 45(6), 586-596.
- . Journal of Neurology, Neurosurgery & Psychiatry, 90(10), 1165-1170.
- . Cell Death & Disease, 10(8).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(7-8), 521-531.
- . Neurology, 92(15_supplement).
- . Neurology, 92(15_supplement).
- . Frontiers in Neurology, 10.
- . Neurology, 92(14), e1610-e1623.
- . Annals of Neurology, 85(4), 470-481.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 20(3-4), 229-234.
- . Brain, 142(3), 586-605.
- . Cell Reports, 26(9), 2298-2306.e5.
- . Neurobiology of Aging, 73, 229.e5-229.e9.
- . Neurology Genetics, 4(6), e279-e279.
- . Acta Neuropathologica Communications, 6(1).
- . Neurobiology of Aging, 71, 266.e1-266.e10.
- . Journal of Molecular Biology, 430(21), 3942-3953.
- . European Journal of Human Genetics, 26(10), 1537-1546.
- . Journal of Neurology, Neurosurgery and Psychiatry.
- . Neurobiology of Aging.
- . Journal of Neurology, Neurosurgery & Psychiatry, 89(10), A33.2-A33.
- . Molecular Therapy : Nucleic Acids, 12, 75-88.
- . Brain, 141(9), 2534-2536.
- . Clinical Biomechanics, 57, 114-120.
- . Annals of Neurology, 1, 110-116.
- . Frontiers in Immunology, 9.
- . Molecular Therapy - Methods and Clinical Development, 9, 81-89.
- . The Lancet Neurology, 17(5), 423-433.
- . Scientific Reports, 8(1).
- . Neuron, 97(6), 1268-1283.e6.
- . Journal of Neuromuscular Diseases, 5(1), 107-107.
- . Journal of Neurology, Neurosurgery, and Psychiatry, 89(3), 248-255.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(5-6), 351-361.
- . Ergonomics, 61(2), 329-338.
- . Therapeutic Targets for Neurological Diseases, 4.
- . Frontiers in Neuroscience, 11.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 19(1-2), 1-3.
- . Journal of Neurology, Neurosurgery & Psychiatry, 88(Suppl 1), A5.2-A5.
- . Molecular Neurodegeneration, 12, 85-85.
- . Frontiers in Molecular Neuroscience, 10, 370-370.
- . Scientific Reports, 7(1).
- . Nature Reviews Disease Primers, 3.
- . Nature Reviews Disease Primers, 3.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-4.
- . Neurology.
- . Genome Research, 27(11), 1895-1903.
- . Nature Neuroscience, 20(9), 1225-1235.
- . Disease Models & Mechanisms, 10(7), 859-868.
- . Nature Communications, 8(-), ---.
- . Neurobiology of Aging, 55, 123-131.
- . Neuroscience Letters.
- . Brain, 140(6), 1611-1618.
- . BMJ Supportive & Palliative Care, 7(2), 189-196.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(5-6), 313-323.
- . BMC Health Services Research, 17.
- . Science Translational Medicine, 9(388).
- . Front. Mol. Neurosci., 10, 123-123.
- . Practical Neurology, 17(2), 96-103.
- . Nature Communications, 8.
- . Acta Neuropathol Commun, 5(1), 23-23.
- . Human Molecular Genetics, 26(6), 1133-1145.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 18(5-6), 378-387.
- . PLoS One.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-6.
- . Amyotrophic Lateral Sclerosis && Frontotemporal Degeneration, 18(1-2), 1-9.
- . Cochrane Database of Systematic Reviews, 2016(12).
- . Proceedings of the National Academy of Sciences, 113(42), E6496-E6505.
- . Nature Neuroscience.
- . PLoS One, 11(10), e0164103-e0164103.
- . Journal of Neuroinflammation, 13(1), 261-261.
- . J Neurol Neurosurg Psychiatry.
- . Practical Neurology, 16, 352-361.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 1-7.
- . Medicine, 44(9), 552-556.
- . Muscle & Nerve, 54(3), 378-385.
- . Nature Reviews Neurology, 12, 526-538.
- . EMBO Journal, 35(15), 1656-1676.
- . Molecular Neurodegeneration, 11(1), 56-56.
- . Nature Genetics, 48(9), 1037-1042.
- . Nature Genetics.
- . JCI Insight, 1(11).
- . JAMA Neurology, 73(7), 812-820.
- . Health Technol Assess, 20(45), 1-186.
- . European Journal of Neurology, 23(6), 1071-1078.
- . Neuropathology and Applied Neurobiology, 42(4), 377-389.
- . Neuroscience, 322, 287-297.
- . The Journal of Pediatrics, 169, 116-121.e2.
- . Neuropathology, 36(2), 125-134.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(7-8), 614-616.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 325-336.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 404-413.
- . Amyotrophic Lateral Sclerosis && Frontotemporal Degeneration, 17(5-6), 313-324.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(5-6), 377-384.
- . Amyotrophic Lateral Sclerosis, 17(5-6), 436-442.
- . Molecular Therapy - Methods and Clinical Development, 3.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 17(3-4), 305-306.
- . Neuropathology and Applied Neurobiology, 42(2), 167-179.
- . Practical Neurology, 16(3), 227-230.
- . Clinical Biomechanics, 32, 201-206.
- . The Lancet Neurology, 14(12), 1153-1153.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 448-455.
- . Neuroscience Letters, 609, 11-17.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 534-535.
- . Frontiers in Cellular Neuroscience, 9.
- . Journal of Medical Engineering & Technology, 39(7), 404-410.
- . Neurobiology of Aging, 36(10), 2908.e17-2908.e18.
- . Neurobiology of Aging, 36(10), 2893-2903.
- . The Lancet Neurology, 14(9), 883-892.
- . Scientific Reports, 5.
- . Scientific Reports, 5(-), ---.
- . BMC Genetics, 16.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 478-484.
- . Acta Neuropathologica, 130(1), 63-75.
- . The Lancet Neurology, 14(7), 702-709.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(7-8), 442-447.
- . Neuropathology and Applied Neurobiology, 41(4), 483-496.
- . PLOS ONE, 10(5), e0127376-e0127376.
- . Expert Opinion on Biological Therapy, 15(7), 935-947.
- . Neurobiology of Aging, 36(5), 2006.e1-2006.e9.
- . Alzheimer's & Dementia, 11(12), 1407-1416.
- . Practical Neurology, 15(4), 280-283.
- . Neurotherapeutics, 12(2), 326-339.
- . Science, 347(6229), 1436-1441.
- . PLoS One, 10(2).
- . Neuropathology and Applied Neurobiology, 41(2), 109-134.
- . Molecular Therapy, 23(2), 270-277.
- . Neuropathology and Applied Neurobiology, 41(2), 201-226.
- , 1-22.
- . Scientific Reports, 5(1).
- . The Lancet Neurology, 14(7), 690-690.
- . Neurobiology of Aging, 36(1), 492-504.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(1-2), 1-7.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(3-4), 249-251.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 16(1-2), 108-113.
- . Journal of Neurology, Neurosurgery & Psychiatry, 86(1), 45-49.
- . Neuropathology and Applied Neurobiology, 40(7), 802-814.
- . Journal of Neurology, Neurosurgery & Psychiatry, 85(11), 1288-1289.
- . Neuron, 84(2), 324-331.
- . Neuropathology and Applied Neurobiology, 40(6), 670-685.
- . PLoS ONE, 9(9), e107918-e107918.
- . Current Opinion in Neurology, 27(5), 524-531.
- . Brain, 137(7), 2040-2051.
- . Annals of Neurology, 76(1), 120-133.
- . Neurobiology of Aging, 35(6), 1499-1509.
- . BMJ Supportive & Palliative Care, 6(1), 52-59.
- . Human Gene Therapy, 25(7), 575-586.
- . Expert Opinion on Orphan Drugs, 2(5), 465-476.
- . Neurology, 82(10_supplement).
- . Neurology, 82(10_supplement).
- . Journal of Aging Science, 2(1).
- . BMJ Supportive & Palliative Care, 4(1), 57-63.
- . Acta Neuropathologica, 127(3), 407-418.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(5-6), 344-350.
- . Cell Death and Disease, 5(2).
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 15(3-4), 285-291.
- . Acta Neuropathologica, 127(3), 333-345.
- . European Journal of Neurology, 21(3), 529-536.
- . Proceedings of the National Academy of Sciences, 111(2), 829-832.
- , 329-350.
- , 703-735.
- . Human Molecular Genetics, 23(8), 2220-2231.
- . Journal of Palliative Medicine, 16(12), 1602-1609.
- . Journal of the Neurological Sciences, 334(1-2), 112-118.
- . Neuropathology and Applied Neurobiology, 39(7), 788-799.
- . BMC Neuroscience, 14(1).
- . Neurology, 81(19), 1719-1721.
- . Colloquium Series on Genomic and Molecular Medicine, 2(2), 1-60.
- . Brain, 136(11), 3305-3332.
- . Palliative Medicine, 27(9), 878-878.
- . Neuro-Ophthalmology, 37(4), 146-156.
- . Neurology, 81(9), 808-811.
- . Neuropathology and Applied Neurobiology, 39(5), 562-571.
- . Human Mutation, 34(8), 1111-1118.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(7-8), 537-545.
- . Free Radical Biology and Medicine, 61, 438-452.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(5-6), 414-423.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(sup1), 19-32.
- . Human Molecular Genetics, 22(18), 3690-3704.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(7-8), 521-527.
- . European Journal of Human Genetics, 21(12), 1429-1435.
- . Molecular Neurodegeneration, 8(1), 12-12.
- . Palliative Medicine, 27(6), 516-523.
- . LANCET NEUROLOGY, 12(3), 310-322.
- . Human Molecular Genetics, 22(12), 2376-2386.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(5-6), 473-475.
- . Molecular Therapy, 21(8), 1486-1496.
- . Neurobiology of Aging, 34(9), 2234.e1-2234.e7.
- . The Lancet Neurology, 12(4), 339-345.
- . Neurobiology of Aging, 34(5), 1517.e5-1517.e7.
- . Annals of Neurology, 73(2), 246-258.
- . Acta Neuropathologica, 125(1), 95-109.
- . Journal of Neurology, Neurosurgery & Psychiatry, 84(1), 79-87.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(2), 96-104.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(2), 105-110.
- . European Journal of Human Genetics, 21(1), 102-108.
- . Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 14(1), 13-19.
- . Angewandte Chemie International Edition, 51(44), 11122-11125.
- . BMC Neurology, 12(1).
- . Nature Reviews Neurology, 8(9), 518-530.
- . Amyotrophic Lateral Sclerosis, 13(6), 528-532.
- . Translational Neuroscience, 3(2).
- . Practical Neurology, 12(3), 166-176.
- . Amyotrophic Lateral Sclerosis, 13(3), 331-331.
- . The Lancet Neurology, 11(4), 323-330.
- Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. The Lancet Neurology.
- . Journal of Neurology, Neurosurgery & Psychiatry, 83(4), 368-369.
- . BMJ Supportive & Palliative Care, 2(Suppl 1), A102.3-A103.
- . Brain, 135(3), 751-764.
- . Medicine, 40(10), 540-545.
- . Neurobiology of Aging, 33(1), 209.e3-209.e8.
- . Journal of Neurology, Neurosurgery & Psychiatry, 83(4), 371-376.
- . Health and Quality of Life Outcomes, 9(1).
- . Acta Neuropathologica, 122(6), 657-671.
- . Neuroscience Letters, 505(1), 25-30.
- Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort. Neuroscience Letters.
- . Nat Rev Neurol, 7(11), 616-630.
- Multiple sclerosis and amyotrophic lateral sclerosis - what is the link? A case series of six patients. MULTIPLE SCLEROSIS JOURNAL, 17, S472-S472.
- PTEN signalling in motor neuron disease (ALS & SMA). HUMAN GENE THERAPY, 22(10), A64-A64.
- Gene therapy approaches to evaluate neuroprotection in experimental models of Amyotrophic Lateral Sclerosis. HUMAN GENE THERAPY, 22(10), A64-A64.
- . Neurobiology of Aging, 32(10), 1795-1807.
- . BMC Neuroscience, 12(1).
- The chromosome 9 ALS and FTD locus is probably derived from a single founder. Neurobiology of Aging.
- . Practical Neurology, 11(5), 296-300.
- . Brain, 134(9), 2627-2641.
- . PLoS ONE, 6(8).
- Non-invasive ventilation in motor neuron disease: An update of current UK practice. Journal of Neurology, Neurosurgery and Psychiatry.
- . Alzheimer's & Dementia, 7(4S_Part_16).
- . Neuropathology and Applied Neurobiology, 37(4), 336-352.
- . Amyotrophic Lateral Sclerosis, 12(6), 464-465.
- . Amyotrophic Lateral Sclerosis, 12(4), 257-263.
- . Brain, 134(2), 506-517.
- . Amyotrophic Lateral Sclerosis.
- . BMC Neurology, 11.
- . Health and Quality of Life Outcomes.
Chapters
- INTERNATIONAL REVIEW OF NEUROBIOLOGY Motor Neurone Disease Preface, MOTOR NEURONE DISEASE (pp. XIX-XX).
- , International Review of Neurobiology (pp. xix-xx). Elsevier
- , Aminoff's Neurology and General Medicine (pp. 285-302). Elsevier
- Gene Therapy in the Nervous System: Failures and Successes In El-Khamisy S (Ed.), Personalised Medicine Lessons from Neurodegeneration to Cancer Springer
- In El-Khamisy (Ed.), Personalised Medicine
- , Advances in Experimental Medicine and Biology (pp. 241-257). Springer International Publishing
- , Neurodegenerative Disorders (pp. 289-303). Springer International Publishing
- , Aminoff's Neurology and General Medicine (pp. vii-xii). Elsevier
- , Goldman's Cecil Medicine (pp. ix-xxx). Elsevier
- , Goldman's Cecil Medicine (pp. 2343-2347). Elsevier
- (pp. 373-401). Wiley
- Gene Expression Profiling and its Application in Amyotrophic Lateral Sclerosis InTech Open Access
- The Neurology of Thyroid Disease In Aminoff M (Ed.), Neurology of Systemic Disease
Conference proceedings papers
- . I: Experimental therapeutics 鈥 preclinical (pp A152.1-A152)
- . Posters
- Two-Year Results from the Open-Label Extension of VALOR: Tofersen in Adults with SOD1-ALS. MUSCLE & NERVE, Vol. 68 (pp S1-S2)
- In-vitro and in-vivo evidence supporting the therapeutic effect of extracellular vesicles derived from mesenchymal stem cells in amyotrophic lateral sclerosis. GLIA, Vol. 71 (pp E280-E281)
- Do deficits in Mitochondrial Spare Respiratory Capacity contribute to Neuropsychological changes seen in Alzheimer's disease?. NEUROLOGY, Vol. 94(15)
- . Biochimica et Biophysica Acta (BBA) - Bioenergetics, Vol. 1859 (pp e23-e23)
- . Journal of the Neurological Sciences, Vol. 381 (pp 304-305)
- . Journal of the Neurological Sciences, Vol. 381 (pp 102-102)
- . The Journal of Pathology, Vol. 240 (pp S1-S48)
- Gene Therapy for Familial ALS Using AAV9 Mediated Silencing of Mutant SOD1. HUMAN GENE THERAPY, Vol. 27(7) (pp A12-A12)
- Experimental modelling of ALS by AAV-mediated in vivo modulation of the C9ORF72 gene. HUMAN GENE THERAPY, Vol. 27(7) (pp A16-A16)
- . NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 42(S1) (pp 28-28), 2 March 2016 - 4 March 2016.
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 86(11) (pp e4.54-e4)
- . Journal of the Neurological Sciences, Vol. 357 (pp e49-e49)
- Elevated creatine kinase is associated with a better prognosis in patients with amyotrophic lateral sclerosis. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22 (pp 741-741)
- Effects of cough augmentation on pulmonary morbidity, survival, and quality of life in patients with amyotrophic lateral sclerosis in respiratory failure: a randomised trial. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 22 (pp 244-244)
- Investigating the mechanisms underlying oligodendrocyte dysfunction in C9ORF72 ALS. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 41 (pp 26-27)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 85(10) (pp e4.130-e4)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 85(10) (pp e4.93-e4)
- A neuronal DNA damage response is detected at low Braak stages and correlates with cognitive impairment in the ageing brain. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 40 (pp 31-32)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 84(11) (pp e2.135-e2)
- Efficient scAAV9-mediated delivery of SMN to motor neurons in neonatal and juvenile mice. HUMAN GENE THERAPY, Vol. 24(5) (pp A38-A38)
- Systemic delivery of scAAV9 expressing PTEN siRNA prolongs survival in a model of spinal muscular atrophy. HUMAN GENE THERAPY, Vol. 24(5) (pp A27-A27)
- A pathological basis for the association of parkinsonism and amyotrophic lateral sclerosis. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 39 (pp 51-51)
- . The Lancet, Vol. 381 (pp S32-S32)
- . The Lancet, Vol. 381 (pp S116-S116)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(Suppl 2) (pp A32.3-A33)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(Suppl 2) (pp A31.3-A31)
- Work in progress: quality of life (QoL) and neurological disease - trajectories of outcome in neurological conditions (TONiC): a study protocol. EUROPEAN JOURNAL OF NEUROLOGY, Vol. 19 (pp 264-264)
- . Neurology, Vol. 78(Meeting Abstracts 1) (pp P03.180-P03.180)
- . Neurology, Vol. 78(Meeting Abstracts 1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.116-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.108-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.110-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.26-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.122-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.115-e1)
- . Journal of Neurology, Neurosurgery & Psychiatry, Vol. 83(3) (pp e1.120-e1)
- Age-dependent penetrance and anticipation in ALS+/-FTLD kindreds due to C9ORF72 hexanucleotide intronic repeat expansion mutations (C9HIREM). DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, Vol. 33 (pp 282-282)
- Age-dependent penetrance and anticipation in ALS+/-FTLD kindreds due to C9ORF72 hexanucleotide intronic repeat expansion mutations (C9HIREM). DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, Vol. 33 (pp 36-37)
- The Use of Non-Invasive Ventilation for Patients with Motor Neurone Disease: Patient and Carer Perceptions of Obstacles and Outcomes. ANNALS OF NEUROLOGY, Vol. 72 (pp S73-S74)
- Microarray analysis of the astrocyte transcriptome in the aging brain: relationship to Alzheimer's pathology and APOE genotype. Neurobiology of Aging
- Congruent handedness and side of onset in ALS-evidence in favour of the exercise hypothesis?. JOURNAL OF NEUROLOGY, Vol. 258 (pp 57-57)
- Impact of Olesoxime on disease related mitochondrial membrane properties in mouse models of neurodegenerative diseases. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, Vol. 383 (pp 51-51)
- Microarray analysis of the astrocyte transcriptome in the ageing brain: relationship to Alzheimer's pathology and ApoE genotype. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 37 (pp 33-33)
- TARDBP mutations, amyotrophic lateral sclerosis and alternative splicing. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, Vol. 37 (pp 20-20)
Other
Preprints
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Research Square Platform LLC.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- , Cold Spring Harbor Laboratory.
- Research group
-
- Adrian Higginbottom
- Laura Evans
- Aytac Gul
- Ilaria Giovanelli
- Simon Bell
- Anushka Bharkava
- Marco Destro
- Ana Aragon Gonzalez
- Allan Shaw
- Tobi Moll
- Calum Harvey
- Selina Beal
- Kriti Gupta
- Kayal Mujthukrishnan
- Deborati Bhattachryya
- Ekene Anakor
- Thomas Marlow
- Raquel Rua Martins
- Aoife Kernan
- Laura Chapman
SITraN PI Scientific Collaborators
- Laura Ferraiuolo
- Robin Highley
- Richard Mead
- Janine Kirby
- Scott Allen
- Guillaume Hautbergue
- Mimoun Azzouz
- Johnathan Cooper-Knock
- James Alix
- Tennore Ramesh
- Ryan West
- Kurt de Vos
- Christopher McDermott
Current Clinical Research Team
- Mbombe Kazoka
- Lee Tuddenham
- Madalina Roman
- Mary Sikaonga
- James Alix
- Stacy Young
- Johnathan Cooper-Knock
- Calum Harvey
- Daniel Madarshahian
- Aoife Kernan
- Grants
-
Principal Funding Sources
- The Motor Neurone Disease Association
- The Medical Research Council
- LifeArc
- NIHR
- My Name鈥5 Doddie Foundation
- European Union
- Pharmaceutical partners
- Professional activities and memberships
-
Professor Shaw has served as a member of multiple national and international committees, and has been a research advisory panel member for the Wellcome Trust, MNDA, MRC, the Muscular Dystrophy Association, the Academy of Medical Sciences, the Academy of Science Finland, NIHR and reviews for multiple grant awarding bodies.
Current Membership of National and International Committees
- Academy of Medical Sciences New Lectureship Panel Fellowship Panel 2020 - present.
- Lister Institute Board of Governors 2018 鈥 present
- UKRI Future Leaders Fellowship Panel and College 2020- present
- NIHR Senior fellowship panel 2021 鈥 present
- Postgraduate awards
- 2022 British Neuroscience Association Award for Outstanding Contribution to Neuroscience
- 2022 Award of the 2nd Dr M Gourie Devi Oration, National Institute of Mental Health and Neuroscience, Bengaluru, India
- 2022 Oktoberfest Plenary Lecture, Ludwig-Maximilian University of Munich
- 2021 Singhal award Lecture XXV World Congress of Neurology, Rome.
- 2019 National Queen鈥檚 Anniversary Prize 2019 for excellence and innovation in Neuroscience awarded to the 91直播 Institute for Translational Neuroscience.
- 2019 European Academy of Neurology Moritz Romberg Lecture
- 2019 Association of British Neurologists 2019 Medallist
- 2018/19 The Physiological Society GL Brown Prize Lectures
- 2018 Science and Society Public Lecture University of Liverpool, June 2018.
- 2017 Honorary Doctor of Medicine, University of Sussex in recognition of major contribution to the field of Neurology.
- 2017 Kosterlitz Prize and Lecture, University of Aberdeen.
- 2017 Honorary Degree, University of Bradford for internationally recognized work in the field of Neurology and instrumental work in setting standards of excellence in the clinical care for patients.
- 2017 Honorary Doctor of Medicine, University of Sussex in recognition of major contribution to the field of Neurology.
- 2017 University of Sussex Brain Visiting Professorship
- 2017 Kosterlitz Lecture, University of Aberdeen.
- 2016 Croonian Lecture, UK Royal College of Physicians
- 2015 Osler Lecture, Association of Physicians of the United Kingdom and Ireland
- 2015 Elected Fellow of the American Association for the Advancement of Science for groundbreaking basic and translational research of relevance to the understanding and treatment of neurodegenerative diseases.
- 2014 Dame Commander of the Order of the British Empire (DBE) for services to Neuroscience
- 2014 Jacobson Visiting Professorship, University of Newcastle upon Tyne
- 2013 Alfred Meyer鈥檚 Memorial Award Lecture British Neuropathological Society
- 2013 NIHR Senior Investigator Award
- 2013 UK ACCEA Platinum Clinical Excellence Award
- 2012 Gary and Peggy Edwards Distinguished Visiting Professorship for ALS, Houston USA
- 2012 Elected President of the North of England Neurological Association
- 2012 Visiting Professorship, Association of Physicians (Kerala Chapter) India
- 2012 Elected to membership of the Medical Pilgrims
- 2007 The International ALS/MND Forbes Norris Award for excellence in research and compassion in clinical care
- 2007 Fellowship of the Academy of Medical Sciences
- 2007 Spinoza Visiting Professorship, University of Amsterdam
- 2006 Royal College of Physicians Jean Hunter Prize for research into nervous disorders
- 2004 Invited Fellowship of the American Neurological Association
- 2001 American Academy of Neurology and ALS Association Sheila Essey Award for outstanding research contribution in amyotrophic lateral sclerosis/ motor neurone disease
- 2000 Hong Kong Neurological Association Li Po Shan/ Dr Vincent Liu visiting Professorship
- 1997 Invited Fellowship of the American Academy of Neurology
- 1996 Renewal of Wellcome Senior Fellowship in Clinical Science
- 1995 British Medical Association Vera Down Award
- 1992 Poster Research prize at the Third International Symposium on ALS/MND
- 1991 Award of Wellcome Senior Fellowship in Clinical Science
- 1991 Association of British Neurologists Sir Charles Symonds Prize
- 1990 North of England Neurological Association Liversedge Research Prize
- 1985 Northern Regional Health Authority David Dickson Research Prize
- 1985 Association of Physicians UK Dewar Research Prize
- 1985 British Cardiac Society Young Investigator of the Year award